Medical Treatment of Glaucoma

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Sun, Xinghuai (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Dai, Yi (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Θέματα: Ophthalmology.; Pharmacology.; Pharmacology/Toxicology.

 This book provides comprehensive information on current medications for glaucoma. From anatomy and physiology of glaucoma related ocular structure to the current mechanism theories and evaluation techniques of glaucoma, our understanding of glaucoma has been considerably improved in the last three decades. A large number of medications have been developed for the treatment of glaucoma, whose pharmacological information and data on efficacy and safety will be introduced in detail in this book. Practical guidelines for different type of glaucoma and specific patients, and pharmaceutical agents combined usage are concise and credible. The other chapters on patient managements and updates on glaucoma guidelines add useful and practical information to the book. New experimental and clinical investigations are promising and may develop new therapeutic targets for treatment of glaucoma in future. The primary target audience for this book is practicing ophthalmologists and ophthalmologists in training. Other healthcare professionals who need information about medical treatment for glaucoma may also find this book valuable. We will provide both evidence-based information and clinical experience on antiglaucoma medications, and guide the clinician on how to use them for the patient's maximal benefit. 

 Glaucoma related ocular structure and function -- Mechanism theories of glaucoma -- Briefs on evaluation techniques for glaucoma -- Medical treatment strategy for glaucoma -- Medical therapy for glaucoma-Principles -- Medical therapy for glaucoma-IOP lowering agents -- Pharmaceutical agents combined usage -- Clinical practice considerations -- Patient managements -- Concluding comments/Authors' preferences for the guidelines.